VLA
Click for more information
0.00% $1.75 viralytics limited

Latest clinical trial results, page-9

  1. morgenlofting
    904 Posts.
    lightbulb Created with Sketch. 119
    clock Created with Sketch.
    11/04/18
    10:50
    Post #: 32370637
    Have to agree there...

    The Nov 2017 update/preso 'flagged' the 'Pivotal Trial/Study' pathway for the MITCI trial for the first time then, which is why I suspected (and still do), that BMS obviously had/have done enough 'homework' (at that stage) on the 'logistics' of realising that outcome to flag it as such, they'd only be in a better position now, with more data, considering this data has a 10/03/18 cutoff...

    Play it by ear I guess...

    ML
    VLA Price at posting: $1.69 Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS New gold-copper assays boost confidence in major porphyry target—discover the potential
right-arrow Created with Sketch.
NEWS Major shallow copper-silver discovery at Junction Prospect confirmed with high-grade intercepts
right-arrow Created with Sketch.
NEWS Kathleen Valley’s first spodumene shipment departs—see how this company is advancing fast
right-arrow Created with Sketch.
NEWS New insights revealed: high-grade lode gold/copper deposit model for El Dovio Project reinterpreted—see the potential
right-arrow Created with Sketch.
NEWS High-grade copper-gold at Mt Isa North—grab samples hit up to 30% Cu and more, with drilling set to begin
right-arrow Created with Sketch.
NEWS Nine-month toxicology study completed, find out which biotech just made a breakthrough
right-arrow Created with Sketch.
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.